Form 4: Corcept Therapeutics Director Exercises Stock Options and Sells Shares
SEC Form 4 Filing
Director Daniel N. Swisher Jr. exercised stock options and sold shares of Corcept Therapeutics on May 1, 2024, according to a Form 4 filing with the SEC.
Summary
- On May 1, 2024, Daniel N. Swisher Jr., a director of Corcept Therapeutics, exercised stock options to acquire 2,200 shares of common stock at a price of $5.86 per share.
- Simultaneously, Swisher sold 2,200 shares of common stock at a price of $23.09 per share.
- The transaction was executed under a pre-existing 10b5-1 trading plan.
- Following the reported transactions, Swisher directly owns 0 shares of Corcept Therapeutics.
- Swisher also holds 4,550 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of a 10b5-1 plan suggests that the transactions were pre-planned and not based on any inside information.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Date of stock option exercise and share sale. |
| 07/21/2026 | Expiration date of the stock options. |
| 05/03/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.